Check out this guide on how to reduce risks with psychedelics.
Read moreDid the Psychedelic Research Bubble Burst?
The psychedelic renaissance is now at a point of reckoning, and the extraordinary promise of these drugs to quickly and easily transform lives for the better is starting to look more like a fever dream.
Read moreRisks with Psychedelics
Researchers should anticipate and track adverse effects in psychedelics research, a group of Maryland-based scientists argue in a paper recently published in Psychedelic Medicine.
For years, the field has been focused on the potential benefits of psychedelics, but the scientists argue that it’s time to pay more attention to understanding the risks.
Adverse Effects
This research study looks at the adverse effects in studies of psychedelics and MDMA.
Read moreRisks of Psychedelics
Here’s a great article on the tendency to deny and downplay the harms of psychedelics.
Read moreMore on HPPD
Here’s another look at HPPD, Hallucinogenic persistent perception disorder.
There are two types of HPPD: type 1 is characterised by brief "flashbacks", and type 2 sufferers experience chronic symptoms that can last months or a lifetime.
Read moreDifficulties Following Psychedelic Use
Explore the extended difficulties following psychedelic use uncovered in a recent study.
Learn about long-term distress and coping strategies.
Read morePodcast: The Shadow Side of Psychedelics
how the nature of capitalism and returning profits to shareholders affects the concept of set and setting; how easy it is to prescribe ketamine and the puppy mill clinics popping up everywhere; how innovators are racing to the bottom to get ahead; the designer drug epidemic likely leading us to a Prozac Nation 2.0; digital narcissism, Instagram “Shamans,” and the dangers of cults; chemists trying to take the experience out of the drug; the overuse of psychedelics creating super egos; and much more.
Read moreRisks with Psychedelics
The most common forms of extended difficulty were feelings of anxiety and fear, existential struggle, social disconnection, depersonalization and derealization.
For approximately one-third of the participants, problems persisted for over a year, and for a sixth, they endured for more than three years.
It was found that a shorter duration of difficulties was predicted by knowledge of dose, drug type and lower levels of difficulty reported during the psychoactive experience, while a narrower range of difficulties was predicted by taking the drug in a guided setting.
Read moreHPPD: Hallucinogen-Persisting Perception Disorder
Here’s a look at HPPD, the persistence of psychedelic-like perceptual phenomena after the acute effects of a psychedelic have worn off. It may be rare, but it is a risk and not well understood.
Read more